Endoscopic Retrograde Cholangiopancreatography Market and Surpass $1,876.75 million by 2027

Emerging Technologies and Growing Prevalence of Biliary and Pancreatic Disorders to Boost the Endoscopic Retrograde Cholangiopancreatography Market Growth

Endoscopy is a medical procedure that enables healthcare professionals to view the internal organs and tissues of the human body in detail, without the need for invasive surgery. Endoscopic retrograde cholangiopancreatography, or ERCP, is a specific type of endoscopy that is used to diagnose and treat disorders of the pancreas and biliary system.

ERCP devices are designed to help healthcare professionals to visualize and access the pancreas and biliary system, and to perform procedures such as removing gallstones, dilating strictures, and placing stents. These devices are becoming increasingly important and widely adopted, due to the growing prevalence of conditions such as biliary disease, pancreatitis, and liver disease.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞 𝐚𝐭: https://www.alliedmarketresearch.com/request-sample/4193

According to Allied Market Research, the global market for 𝐄𝐑𝐂𝐏 𝐰𝐚𝐬 𝐯𝐚𝐥𝐮𝐞𝐝 𝐚𝐭 $1,212.94 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 2019 𝐚𝐧𝐝 𝐢𝐬 𝐞𝐱𝐩𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐠𝐫𝐨𝐰 𝐚𝐭 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 5.6% 𝐟𝐫𝐨𝐦 2019 𝐭𝐨 2027, 𝐫𝐞𝐚𝐜𝐡𝐢𝐧𝐠 𝐚 𝐩𝐫𝐨𝐣𝐞𝐜𝐭𝐞𝐝 𝐯𝐚𝐥𝐮𝐞 𝐨𝐟 $1,876.75 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 2027. This growth is driven by several factors, including an increasing incidence of gastrointestinal diseases and a growing demand for minimally invasive diagnostic and therapeutic procedures.

𝐓𝐡𝐞 𝐂𝐎𝐕𝐈𝐃-19 𝐩𝐚𝐧𝐝𝐞𝐦𝐢𝐜 has had a significant impact on many aspects of healthcare, including endoscopic services. Given that COVID-19 is primarily spread through contact and droplets, healthcare providers of endoscopy are facing increased risks during the pandemic, as endoscopy procedures require close physical proximity between patients and personnel.

A report from Hong Kong, based on experience with SARS, found that the risk of infection was 5% for physicians, 4% for nurses, and 8% for healthcare assistants. This underscores the importance of implementing strict isolation and infection control measures, as well as the use of personal protective equipment (PPE), to minimize the risk of transmission during endoscopy procedures.

𝐑𝐞𝐠𝐢𝐨𝐧 𝐬𝐞𝐠𝐦𝐞𝐧𝐭 𝐫𝐞𝐯𝐢𝐞𝐰

𝐓𝐡𝐞 𝐦𝐚𝐫𝐤𝐞𝐭 𝐢𝐬 𝐠𝐞𝐨𝐠𝐫𝐚𝐩𝐡𝐢𝐜𝐚𝐥𝐥𝐲 𝐝𝐢𝐯𝐢𝐝𝐞𝐝 𝐢𝐧𝐭𝐨 𝐬𝐞𝐯𝐞𝐫𝐚𝐥 𝐫𝐞𝐠𝐢𝐨𝐧𝐬, 𝐢𝐧𝐜𝐥𝐮𝐝𝐢𝐧𝐠 𝐍𝐨𝐫𝐭𝐡 𝐀𝐦𝐞𝐫𝐢𝐜𝐚, 𝐄𝐮𝐫𝐨𝐩𝐞, 𝐀𝐬𝐢𝐚-𝐏𝐚𝐜𝐢𝐟𝐢𝐜, 𝐋𝐚𝐭𝐢𝐧 𝐀𝐦𝐞𝐫𝐢𝐜𝐚, 𝐚𝐧𝐝 𝐭𝐡𝐞 𝐌𝐢𝐝𝐝𝐥𝐞 𝐄𝐚𝐬𝐭 𝐚𝐧𝐝 𝐀𝐟𝐫𝐢𝐜𝐚.

𝐍𝐨𝐫𝐭𝐡 𝐀𝐦𝐞𝐫𝐢𝐜𝐚 was the largest market for ERCP devices in 2019, owing to the high expenditure on research and development (R&D), the presence of major players in the region, and a well-established healthcare infrastructure. In addition, the availability of advanced medical technologies and the increasing prevalence of pancreas and biliary system-related disorders in the region are expected to drive the market growth in the coming years.

However, 𝐭𝐡𝐞 𝐀𝐬𝐢𝐚-𝐏𝐚𝐜𝐢𝐟𝐢𝐜 𝐫𝐞𝐠𝐢𝐨𝐧 is expected to register the highest CAGR during the forecast period, due to the increasing investments by governments of Asian countries in healthcare infrastructure development. The rising prevalence of pancreas and biliary system-related disorders in the region, coupled with the increasing adoption of ERCP devices, is also expected to drive the market growth in the coming years. Additionally, the availability of low-cost ERCP devices in the region is expected to increase the demand for these devices among healthcare providers.

𝐄𝐮𝐫𝐨𝐩𝐞 is also expected to witness significant growth in the ERCP device market, due to the increasing incidence of pancreas and biliary system-related disorders, and the presence of well-established healthcare infrastructure in the region. Latin America and the Middle East and Africa are also expected to witness growth in the market, owing to the increasing awareness about ERCP devices and the rising demand for advanced medical technologies in these regions.

𝐈𝐧𝐪𝐮𝐢𝐫𝐲 𝐁𝐞𝐟𝐨𝐫𝐞 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞: https://www.alliedmarketresearch.com/purchase-enquiry/4193

𝐒𝐨𝐦𝐞 𝐨𝐟 𝐭𝐡𝐞 𝐤𝐞𝐲 𝐩𝐥𝐚𝐲𝐞𝐫𝐬 𝐨𝐩𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐢𝐧 𝐭𝐡𝐞 𝐠𝐥𝐨𝐛𝐚𝐥 𝐞𝐧𝐝𝐨𝐬𝐜𝐨𝐩𝐢𝐜 𝐫𝐞𝐭𝐫𝐨𝐠𝐫𝐚𝐝𝐞 𝐜𝐡𝐨𝐥𝐚𝐧𝐠𝐢𝐨𝐩𝐚𝐧𝐜𝐫𝐞𝐚𝐭𝐨𝐠𝐫𝐚𝐩𝐡𝐲 𝐦𝐚𝐫𝐤𝐞𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞

1. Olympus
2. Conmed
3. Hobbs Medical
4. TeleMed Systems
5. Boston Scientific
6. Cook Group
7. Ambu
8. Becton
9. Dickinson and Company
10. Fujifilm Holding
11. and Medtronic Plc

𝐊𝐞𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐬

Endoscopic retrograde cholangiopancreatography (ERCP) is a medical procedure that involves the use of an endoscope to diagnose and treat diseases of the pancreas and biliary system. The global ERCP market is segmented based on product type and application.

𝐏𝐫𝐨𝐝𝐮𝐜𝐭 𝐓𝐲𝐩𝐞:
The product type segment is further divided into endoscopes, endotherapy devices, imaging devices, energy devices, and others. The endoscopes sub-segment accounted for the largest share of the ERCP market in 2019. Endotherapy devices are further divided into sphincterotome, lithotripter, stents, cannulas, forceps, snares, catheters, guiding wires, balloons, baskets, and others. Imaging devices include ultrasound, X-ray, and magnetic resonance cholangiopancreatography (MRCP). Energy devices include electrocautery and laser devices.

𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧:
The application segment is further divided into biliary sphincterotomy, biliary dilatation, biliary stenting, pancreatic sphincterotomy, pancreatic duct dilatation, and pancreatic duct stenting. Biliary sphincterotomy is a procedure that involves making a small incision in the muscle surrounding the bile duct to relieve blockages. Biliary dilatation is a procedure that involves widening the bile duct to remove blockages. Biliary stenting is a procedure that involves placing a stent in the bile duct to keep it open. Pancreatic sphincterotomy is a procedure that involves making a small incision in the muscle surrounding the pancreatic duct to relieve blockages. Pancreatic duct dilatation is a procedure that involves widening the pancreatic duct to remove blockages. Pancreatic duct stenting is a procedure that involves placing a stent in the pancreatic duct to keep it open.

𝐆𝐞𝐨𝐠𝐫𝐚𝐩𝐡𝐢𝐜 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧:
The global ERCP market is also segmented geographically into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. North America is the largest market for ERCP devices, owing to the high expenditure on research and development, presence of major players, and a well-established healthcare infrastructure. However, Asia-Pacific is expected to register the highest CAGR during the forecast period, due to increasing investments in healthcare infrastructure development and rising demand for advanced medical technologies.

In conclusion, the ERCP market is segmented based on product type, application, and geography. The product type segment is further divided into endoscopes, endotherapy devices, imaging devices, energy devices, and others, while the application segment is further divided into biliary sphincterotomy, biliary dilatation, biliary stenting, pancreatic sphincterotomy, pancreatic duct dilatation, and pancreatic duct stenting. The geographic segmentation includes North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.

𝐁𝐮𝐲 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐄𝐧𝐝𝐨𝐬𝐜𝐨𝐩𝐢𝐜 𝐑𝐞𝐭𝐫𝐨𝐠𝐫𝐚𝐝𝐞 𝐂𝐡𝐨𝐥𝐚𝐧𝐠𝐢𝐨𝐩𝐚𝐧𝐜𝐫𝐞𝐚𝐭𝐨𝐠𝐫𝐚𝐩𝐡𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐆𝐫𝐨𝐰𝐭𝐡 𝐑𝐞𝐩𝐨𝐫𝐭 𝐚𝐭: https://www.alliedmarketresearch.com/endoscopic-retrograde-cholangiopancreatography-market/purchase-options

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP, based in Portland, Oregon. AMR provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients in making strategic business decisions and achieving sustainable growth in their respective market domains.
AMR launched its user-based online library of reports and company profiles, Avenue. An e-access library is accessible from any device, anywhere, and at any time for entrepreneurs, stakeholders, researchers, and students at universities. With reports on more than 60,000 niche markets with data comprising of 600,000 pages along with company profiles on more than 12,000 firms, Avenue offers access to the entire repository of information through subscriptions. A hassle-free solution to clients' requirements is complemented with analyst support and customization requests.

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll-Free: 1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Follow Us on: LinkedIn Twitter

This release was published on openPR.